Cerebrospinal fluid β-amyloid and tau are not associated with risk of delirium: A prospective cohort study in older adults with hip fracture

Journal of the American Geriatrics Society

Volumn 59, Issue 7, 2011, Pages 1260-1267

  Witlox, Joost ^a   Kalisvaart, Kees J ^b   De Jonghe, Jos F M ^a   Verwey, Nicolaas A ^c   Van Stijn, Mireille F M ^a   Houdijk, Alexander P J ^a   Traast, Han S ^a   MacLullich, Alasdair M J ^d   Van Gool, Willem A ^e   Eikelenboom, Piet ^e,f  

^a Location Alkmaar   (Netherlands)

^b Kennemer Gasthuis ^*  (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f GGZinGeest   (Netherlands)

Author keywords

A ; cerebrospinal fluid; delirium; hip fracture; tau

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ADL DISABILITY; AGED; ANESTHESIST; APACHE; ARTICLE; BARTHEL INDEX; COGNITIVE DEFECT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DELIRIUM; FEMALE; GENERAL HOSPITAL; GERIATRIC DEPRESSION SCALE; HIP FRACTURE; HUMAN; LAWTON INSTRUMENTAL ACTIVITIES OF DAILY LIVING SCALE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MINI MENTAL STATE EXAMINATION; NETHERLANDS; PATIENT ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN PHOSPHORYLATION; QUESTIONNAIRE; RISK ASSESSMENT; SPINAL ANESTHESIA; UNIVERSITY HOSPITAL; VISUAL IMPAIRMENT;

AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; COGNITION DISORDERS; COHORT STUDIES; DELIRIUM; FEMALE; HIP FRACTURES; HUMANS; MALE; PEPTIDE FRAGMENTS; PHOSPHORYLATION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TAU PROTEINS;

EID: 79960418870     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03482.x     Document Type: Article

References (40)

1. Witlox J, Eurelings LS, de Jonghe JFM, et al,. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: A meta-analysis. JAMA 2010; 304: 443-451.
2. Bruce AJ, Ritchie CW, Blizard R, et al,. The incidence of delirium associated with orthopedic surgery: A meta-analytic review. Int Psychogeriatr 2007; 19: 197-214. (Pubitemid 46393208)
3. Elie M, Cole MG, Primeau FJ, et al,. Delirium risk factors in elderly hospitalized patients. J Gen Intern Med 1998; 13: 204-212. (Pubitemid 28129001)
4. Dasgupta M, Dumbrell AC., Preoperative risk assessment for delirium after noncardiac surgery: A systematic review. J Am Geriatr Soc 2006; 54: 1578-1589. (Pubitemid 44564155)
5. Eikelenboom P, Hoogendijk WJ., Do delirium and Alzheimer's dementia share specific pathogenetic mechanisms? Dement Geriatr Cogn Disord 1999; 10: 319-324. (Pubitemid 29403587)
6. Selkoe DJ., The molecular pathology of Alzheimer's disease. Neuron 1991; 6: 487-498.
7. Savva GM, Wharton SB, Ince PG, et al,. Age, neuropathology, and dementia. N Engl J Med 2009; 360: 2302-2309.
8. Bennett DA, Schneider JA, Arvanitakis Z, et al,. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006; 66: 1837-1844. (Pubitemid 44049813)
9. Price JL, McKeel DW Jr, Buckles VD, et al,. Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging 2009; 30: 1026-1036.
10. Blennow K, Hampel H., CSF markers for incipient Alzheimer's disease. Lancet Neurol 2003; 2: 605-613. (Pubitemid 37162569)
11. Morris JC, Price AL., Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 2001; 17: 101-118. (Pubitemid 33063515)
12. de Jong D, Kremer BP, Olde Rikkert MG, et al,. Current state and future directions of neurochemical biomarkers for Alzheimer's disease. Clin Chem Lab Med 2007; 45: 1421-1434. (Pubitemid 350036575)
13. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, et al,. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: A randomized placebo-controlled study. J Am Geriatr Soc 2005; 53: 1658-1666. (Pubitemid 43109927)
14. Folstein MF, Folstein SE, McHugh PR., "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
15. Jorm AF, Jacomb PA., The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): Socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989; 19: 1015-1022. (Pubitemid 20012268)
16. de Jonghe JFM, Schmand B, Ooms ME, et al,. Abbreviated form of the Informant Questionnaire on Cognitive Decline in the Elderly. Tijdschr Gerontol Geriatr 1997; 28: 224-229. (Pubitemid 27468166)
17. Hetherington R., The Snellen chart as a test of visual acuity. Psychol Forsch 1954; 24: 349-357.
18. Knaus WA, Draper EA, Wagner DP, et al,. APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829. (Pubitemid 15250137)
19. Yesavage JA, Brink TL, Rose TL, et al,. Development and validation of a Geriatric Depression Screening Scale: A preliminary report. J Psychiatr Res 1982; 17: 37-49. (Pubitemid 13123113)
20. Mahoney FI, Barthel DW., Functional evaluation: The Barthel index. MD State Med J 1965; 14: 61-65.
21. Lawton MP, Brody EM., Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-186.
22. ASA Physical Status Classification System. American Society of Anesthesiologists [on-line]. Available at Accessed January 25, 2010.
23. Schoonenboom NS, Pijnenburg YA, Mulder C, et al,. Amyloid beta(1-42) and phosphorylated tau in CSF as markers for early-onset Alzheimer disease. Neurology 2004; 62: 1580-1584. (Pubitemid 38608199)
24. Mulder C, Verwey NA, van der Flier WM, et al,. Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin Chem 2010; 56: 248-253.
25. Inouye SK, van Dyck CH, Alessi CA, et al,. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med 1990; 113: 941-948.
26. Hansson O, Zetterberg H, Buchhave P, et al,. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: A follow-up study. Lancet Neurol 2006; 5: 228-234. (Pubitemid 43238346)
27. Inouye SK, Zhang Y, Han L, et al,. Recoverable cognitive dysfunction at hospital admission in older persons during acute illness. J Gen Intern Med 2006; 21: 1276-1281. (Pubitemid 44665336)
28. Sunderland T, Linker G, Mirza N, et al,. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. JAMA 2003; 289: 2094-2103. (Pubitemid 37430211)
29. Mattsson N, Zetterberg H, Hansson O, et al,. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 2009; 302: 385-393.
30. Marcantonio ER, Flacker JM, Michaels M, et al,. Delirium is independently associated with poor functional recovery after hip fracture. J Am Geriatr Soc 2000; 48: 618-624. (Pubitemid 30390450)
31. Bouwman FH, Schoonenboom NS, Verwey NA, et al,. CSF biomarker levels in early and late onset Alzheimer's disease. Neurobiol Aging 2009; 30: 1895-1901.
32. Kester MI, Blankenstein MA, Bouwman FH, et al,. CSF biomarkers in Alzheimer's disease and controls: Associations with APOE genotype are modified by age. J Alzheimers Dis 2009; 16: 601-607.
33. Schneider JA, Arvanitakis Z, Bang W, et al,. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 2007; 69: 2197-2204. (Pubitemid 350294674)
34. Robertsson B, Blennow K, Gottfries CG, et al,. Delirium in dementia. Int J Geriatr Psychiatry 1998; 13: 49-56. (Pubitemid 28046030)
35. Rudolph JL, Jones RN, Rasmussen LS, et al,. Independent vascular and cognitive risk factors for postoperative delirium. Am J Med 2007; 120: 807-813. (Pubitemid 47313345)
36. Soiza RL, Sharma V, Ferguson K, et al,. Neuroimaging studies of delirium: A systematic review. J Psychosom Res 2008; 65: 239-248.
37. Maclullich AM, Ferguson KJ, Miller T, et al,. Unravelling the pathophysiology of delirium: A focus on the role of aberrant stress responses. J Psychosom Res 2008; 65: 229-238.
38. van Gool WA, van der Beek D, Eikelenboom P., Systemic infection and delirium: When cytokines and acetylcholine collide. Lancet 2010; 375: 773-775.
39. Verwey NA, van der Flier WM, Blennow K, et al,. A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem 2009; 46: 235-240.
40. Mattsson N, Blennow K, Zetterberg H., Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: United we stand, divided we fall. Clin Chem Lab Med 2010; 48: 603-607.